| Michael John Solomon, DO | |
|
9228 Medical Plaza Dr, Charleston, SC 29406-9125 | |
| (843) 572-8277 | |
| Not Available |
| Full Name | Michael John Solomon |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 8 Years |
| Location | 9228 Medical Plaza Dr, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922458850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | DR.0062649 (Colorado) | Secondary |
| 207Q00000X | Family Medicine | LL39788 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Littleton Adventist Hospital, Centura Health | Littleton, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Portercare Adventist Health System | 0941110886 | 547 |
News Archive
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
Where does the benefit lie in an afternoon nap? Is it in the nap itself-or in the anticipation of taking a snooze? Researchers in the United Kingdom have found that the time just before you fall asleep is where beneficial cardiovascular changes take place.
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.
› Verified 9 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
Where does the benefit lie in an afternoon nap? Is it in the nap itself-or in the anticipation of taking a snooze? Researchers in the United Kingdom have found that the time just before you fall asleep is where beneficial cardiovascular changes take place.
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.
› Verified 9 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
Where does the benefit lie in an afternoon nap? Is it in the nap itself-or in the anticipation of taking a snooze? Researchers in the United Kingdom have found that the time just before you fall asleep is where beneficial cardiovascular changes take place.
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael John Solomon, DO 9228 Medical Plaza Dr, Charleston, SC 29406-9125 Ph: (843) 572-8277 | Michael John Solomon, DO 9228 Medical Plaza Dr, Charleston, SC 29406-9125 Ph: (843) 572-8277 |
News Archive
Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.
Where does the benefit lie in an afternoon nap? Is it in the nap itself-or in the anticipation of taking a snooze? Researchers in the United Kingdom have found that the time just before you fall asleep is where beneficial cardiovascular changes take place.
The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association and the Heart Rhythm Society.
Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease
Boehringer Ingelheim today announced that Striverdi Respimat (olodaterol) Inhalation Spray 5 mcg is now available by prescription in pharmacies across the United States.
› Verified 9 days ago
Huyen Bui, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 650 Ellis Oak Dr, Charleston, SC 29412 Phone: 843-792-3451 | |
Dr. Charles T Tweel, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 51 Nassau St, Charleston, SC 29403 Phone: 803-722-4112 | |
Alexander Chessman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Justin William Dean, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2125 Charlie Hall Bvld, Ste 2, Charleston, SC 29414 Phone: 843-876-3151 | |
Yolanda Bryant, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
Dr. Donald P Hurley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2270 Ashley Crossing Dr Ste 150, Charleston, SC 29414 Phone: 843-766-1936 Fax: 843-766-1206 | |
Dr. John David Williamson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 316 Calhoun St, Charleston, SC 29401 Phone: 843-402-1000 |